Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -102

Accepted - Volume 3

Comment Record
Commentor Ms. Marla Hickey Date/Time 2002-11-03 10:00:31
Organization Portsmouth Early Education Program
Category Academic

Comments for FDA General
Questions
1. General Comments I strongly oppose using young children to test Dryvax as it IS such a risky proposition. Anything that could potentially have a negative effect on a single child's brain or neurological development is totally unacceptable.




EC -102